Form 8-K Akebia Therapeutics, For: Mar 14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq futures outperform after Nvidia puts AI fears to rest
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil gains as traders weigh prospects of easing Middle East supply disruptions
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
Akebia Therapeutics (AKBA) Announces CFO Transition
March 15, 2024 4:09 PM EDTOn March 15, 2024, Akebia Therapeutics (NASDAQ: AKBA) and Ellen Snow mutually agreed that she would transition from her role as the Companys Senior Vice President, Chief Financial Officer and Treasurer, effective March 22, 2024 (the Transition Date).
... More